Zurich Cantonal Bank’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Zurich Cantonal Bank’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,825	Closed	-$381K	–	2897
2023 Q1	$381K	Buy	15,825 +2,398	+18%	+$30.1K	﹤0.01%	1457
2022 Q4	$142K	Buy	13,427 +8,439	+169%	+$68.1K	﹤0.01%	2043
2022 Q3	$22K	Hold	4,988	–	–	﹤0.01%	2787
2022 Q2	$20K	Hold	4,988	–	–	﹤0.01%	2799
2022 Q1	$37K	Sell	4,988 -2,967	-37%	-$17.7K	﹤0.01%	2586
2021 Q4	$45K	Sell	7,955 -308	-4%	-$1.96K	﹤0.01%	2772
2021 Q3	$53K	Buy	8,263 +16	+0.2%	+$103	﹤0.01%	2597
2021 Q2	$70K	Buy	8,247 +341	+4%	+$2.75K	﹤0.01%	2363
2021 Q1	$83K	Buy	7,906 +2,918	+59%	+$41.1K	﹤0.01%	2226
2020 Q4	$84K	Hold	4,988	–	–	﹤0.01%	2281
2020 Q3	$64K	Buy	4,988 +3,051	+158%	+$38.5K	﹤0.01%	2176
2020 Q2	$27K	Buy	+1,937	New	+$24.5K	﹤0.01%	2407

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Zurich Cantonal Bank's PRVB Position: Q2 2023 in Review

Zurich Cantonal Bank sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 15,825 shares — an estimated $381K sold.

Zurich Cantonal Bank first reported a position in PRVB in Q2 2020 and held it in 12 quarters. The position peaked at $381K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Zurich Cantonal Bank reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Zurich Cantonal Bank sold 15,825 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $381K.
Zurich Cantonal Bank first reported a position in Provention Bio, Inc. Common Stock in Q2 2020 and held it in 12 quarters.
Zurich Cantonal Bank's Provention Bio, Inc. Common Stock position peaked at $381K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Zurich Cantonal Bank's 13F filing for Q2 2023, filed 7 Aug 2023.